Noster Inc.

21 patents currently held · Updated Nov 14, 2026

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Nov 2032

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Feb 22, 2027
The maintenance fee for Lipopolysaccharide-regulated enteric bacteria and use thereof (US 11,730,772) comes due Feb 22, 2027. Unpaid by Aug 23, 2027, it lapses early.
1 fee due Jun 17, 2027
The maintenance fee for Novel Lactic Acid Bacterium and Composition Including Said Lactic Acid Bacterium (US 10,507,222) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
1 fee due Aug 4, 2027
The maintenance fee for Metabolism-Improving Agent Comprising Rare Fatty Acid (US 10,548,868) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,294,501	Method for Producing Oxo Fatty Acid and Rare Fatty Acid In force Term ends Nov 6, 2032 · Medium confidence	In force	Term ends Nov 6, 2032	Medium confidence
US 10,975,397	Method for Producing Oxo Fatty Acid and Rare Fatty Acid In force Term ends Nov 6, 2032 · High confidence	In force	Term ends Nov 6, 2032	High confidence
US 9,719,115	Method for Producing Oxo Fatty Acid and Rare Fatty Acid In force Term ends Nov 12, 2032 · High confidence	In force	Term ends Nov 12, 2032	High confidence
US 9,707,200	Metabolism-Improving Agent Comprising Rare Fatty Acid In force Term ends Oct 14, 2033 · High confidence	In force	Term ends Oct 14, 2033	High confidence
US 9,539,229	Intestinal Tract-Protecting Agent Containing Hydroxylated Fatty Acid In force Term ends Feb 13, 2034 · High confidence	In force	Term ends Feb 13, 2034	High confidence
US 9,572,844	Immunostimulation Agent In force Term ends Feb 21, 2034 · High confidence	In force	Term ends Feb 21, 2034	High confidence
US 10,093,749	Exopolysaccharide Produced by Lactic Acid Bacterium In force Term ends Nov 25, 2034 · High confidence	In force	Term ends Nov 25, 2034	High confidence
US 10,952,983	Metabolism-Improving Agent Comprising Rare Fatty Acid In force Term ends Jan 23, 2035 · High confidence	In force	Term ends Jan 23, 2035	High confidence
US 12,491,173	Metabolism-Improving Agent Comprising Rare Fatty Acid In force Term ends Mar 10, 2035 · High confidence	In force	Term ends Mar 10, 2035	High confidence
US 12,697,318	Anti-Inflammatory Agent Containing Rare Fatty Acid In force Term ends Jul 31, 2035 · Medium confidence	In force	Term ends Jul 31, 2035	Medium confidence

10 of 21 patents shown.

Pro members see all 21.

Pro members: see all 21 patents

Also on record, not counted in the 21: 1 patent in force now held by others · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 1 abandoned

List them